Clinical trial
Retrospective Study of AML Relapses Using Targeted NGS Analysis
NCT03582241 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study of AML Relapses Using Targeted NGS Analysis
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 27, 2018
- Completion date
- June 30, 2019
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia